Indications for: SPIKEVAX
Active immunization to prevent COVID-19 in individuals ≥18yrs of age.
Give by IM inj only. ≥18yrs: 0.5mL given as a 2-dose series 1 month apart.
<18yrs: not established.
Have epinephrine inj available. Increased risks of myocarditis and pericarditis (esp. within 7 days after the second dose); higher risk among males <40yrs of age, and highest among males 18–24yrs of age. Syncope. Immunocompromised. Pregnancy. Nursing mothers.
Immunosuppressants: may get suboptimal response.
Inj site reactions (eg, pain, swelling, tenderness, erythema), fatigue, headache, muscle pain, chills, joint pain, fever, nausea/vomiting.
To enroll in the pregnancy exposure registry, call (866) 663-3762.
Generic Drug Availability:
Multiple-dose vials (5.5mL, 7.5mL)—10